Blackbird plc (BIRD) — Research Note
Executive summary
Blackbird is an AIM-listed cloud video editing technology company with two products: the legacy enterprise SaaS platform Blackbird (sports/news broadcast workflows) and elevate.io, a new browser-based collaborative video editor launched into general release in March 2024 and monetised from February 2025. The operating trajectory over the period covered is one of deteriorating top line (revenue fell from £2.85m in 2022 to £1.38m in 2025), persistent operating losses (~£2.3m–£2.6m net loss every year since 2022), and a balance sheet repeatedly topped up by dilutive equity raises at progressively lower prices (28p in Dec 2021 → 6p in Feb 2024 → 3p in Jul 2025). The single most important point for valuation today is that the stock is a venture-stage option on elevate.io reaching product–market fit; current paying subscribers stand at 388 with ARR of US$52k (£40k) 2026-03 final results, while the core Blackbird business is structurally shrinking but newly EBITDA-positive on a divisional basis.
Fair value estimate
Methodology: sum-of-the-parts (cash + Blackbird division multiple + elevate.io optionality).
- Cash & investments at year-end 2025: £2.72m + £0.47m Jan 2026 raise = ~£3.2m
- Blackbird division: 2025 adjusted EBITDA £0.71m, but revenue declining (£1.38m group revenue, down 14% YoY) and contracted backlog falling — capitalise at 3–5× adjusted EBITDA = £2.0–3.5m, adjusted down for decline and customer losses (US State Dept, Arsenal, MSG, A+E)
- elevate.io optionality: ARR ~£40k, 1.1% free-to-paid conversion, 388 active subscribers, 138k registered users — at 5–15× ARR with discount for pre-PMF execution risk = £0.2–2.0m; bull-case >£10m if monetisation curve inflects, near-zero if it stalls
- Continued cash burn (~£3m/yr) before any further fundraise — netted off in central case
| Scenario | Cash | Blackbird | elevate.io | Total mcap | Per share (~458m shares) |
|---|---|---|---|---|---|
| Bear | £1.0m | £1.5m | £0.0m | £2.5m | 0.5p |
| Central | £2.0m | £2.5m | £2.0m | £6.5m | 1.4p |
| Bull | £2.5m | £3.5m | £8.0m | £14.0m | 3.1p |
Fair value range: 1.0p – 2.0p per share, implying market cap £4.5m – £9.0m, mid ~£6.7m.
Latest disclosed market cap is £9.8m (~2.14p/share). Downside vs mid: ~-30%. The current price already requires the bull case for elevate.io to be largely correct.
Sector context
ICB Technology / Technology — confirmed. This sits in the "vertical SaaS / creator tools" sub-segment. The quality profile is below typical peers: it is a micro-cap pre-PMF SaaS attempt embedded inside a structurally shrinking legacy business, with persistent losses and dilutive capital raises. Closest listed analogues by category (not size) are: Adobe (ADBE) — direct competitor with Premiere Pro, dominant incumbent; Synchronoss / Limelight-type small caps — also struggling cloud-media vendors; and Canva (private) as the "Figma for video" analogue Blackbird explicitly cites. Versus these peers Blackbird is sub-scale, sub-marginal, and capital-constrained.
Investment thesis (3 bullets)
- Underlying patented cloud codec / video tech is real and battle-tested. The Blackbird platform was used on the 2024 Summer Games, FIFA, Winter Games 2026 (via OEM partner), CBS Sports and IMG — a credible technology base that has signed at least one OEM licensing deal (EVS, "Powered by Blackbird") 2024-03 final results. The Blackbird division turned EBITDA-positive in 2024 (£0.49m) and improved to £0.71m in 2025 2026-03 final results.
- elevate.io traction in registered users is non-trivial. 138,000 registered users by March 2026, ~1,400 monthly returning active users in Feb 2026, conversion rate has held around 1.1% 2026-03 final results. If the conversion curve inflects post-funding-driven marketing push, the SaaS leverage on a fixed cost base could be material.
- Clean balance sheet — no debt, ~£3.2m cash post Jan 2026 raise 2026-03 final results. Provides at least 12 months of runway and reduces near-term going-concern risk.
Key risks (3 bullets)
- Revenue is in multi-year decline and customer losses continue. Group revenue fell from £2.85m (2022) → £1.94m (2023) → £1.61m (2024) → £1.38m (2025). 2025 saw the loss of US Department of State, Arsenal and MSG 2026-03 final results. Contracted-but-unrecognised revenue dropped 33% YoY at year-end 2025 2026-03 final results.
- elevate.io monetisation is far below the implied trajectory. Paid subscribers were "circa 100" in early March 2025 2025-03 final results, peaked at 697 cumulative signups but only 344 active by Sep 2025 2025-09 interim, and stood at 388 paying with ARR ~$52k by mid-March 2026 2026-03 final results — i.e. roughly flat for 6 months on $40k of annual revenue against an 8-figure cumulative investment.
- Repeated dilution at declining prices. Placings at 28p (Dec 2021, £8.0m), 6p (Feb 2024, £1.05m), 3p (Jul 2025, £2.0m), and a further £0.5m subscription Jan 2026. Cash burn ~£3m/year on £1.4m revenue makes further dilution near-certain unless elevate.io inflects fast 2025-07 placing announcement, 2026-03 final results.
Operating leverage
The cost base is overwhelmingly fixed: 2025 operating costs of £2.95m on revenue of £1.38m, with gross margin ~88% (cost of sales only £170k) 2026-03 final results. R&D spend is also substantial — £1.55m capitalised in 2025 on top of P&L opex. In principle the model has extreme operating leverage: at current run-rate, a doubling of revenue would more than eliminate operating losses, and tripling would deliver meaningful operating profit, because the cost base barely scales with subscribers (this is a classic capital-light SaaS profile). The Blackbird division has demonstrated this — same revenue base, restructured cost base, swing from -£365k to +£710k adjusted EBITDA over two years 2026-03 final results. The problem is direction of revenue: operating leverage cuts both ways, and currently it cuts the wrong way. The genuine inflection point would be elevate.io paying-subscriber growth re-accelerating from the current ~390 to several thousand on the existing cost base — that would convert almost entirely to gross margin. There is no evidence of that yet.
Value-trap signals
- Revenue declining every year for four consecutive years (2022→2025: -52% cumulative)
- Repeated dilutive raises at progressively lower share prices (28p → 6p → 3p)
- "Strategic pivots" — from M&E broadcast (2018–2022) to "Powered by Blackbird" licensing (2022) to Creator SaaS (2023) to Creator/SMB ICP (mid-2025) to "marketing teams + creators" (2026)
- Chair departure mid-2025 followed by restructuring; CEO restructured into Executive Chair role
- elevate.io paid-user numbers stalled / shrunk H2 2025 (697 cumulative → 344 active → 388 active)
- Auditor remains Moore Kingston Smith (unqualified opinions), no related-party flags, but the equity story has repeatedly been "the best is ahead" through multiple disappointments
Earnings vs expectations
Across the period covered, management consistently guided to growth re-acceleration; actuals consistently disappointed. 2023 results missed prior-year revenue by 32%; 2024 missed 2023 by 17%; 2025 missed 2024 by 14%. On elevate.io, the March 2025 guidance implied "circa 100 paid subscribers" was an early positive datapoint that would scale with marketing; by September 2025 the company reported 697 cumulative signups but only 344 active, then 388 active by March 2026 — i.e. paid-user growth essentially stalled. There is no visible sell-side consensus referenced in the filings (the stock has no broker estimates discussed), so management guidance is the only benchmark. Pattern: repeated revenue misses on the legacy business, repeated soft delivery vs implied marketing-led growth on elevate.io.
Conviction
3 — moderate.
Anchors: (i) disclosure is detailed and audit reports are unqualified; (ii) sum-of-parts methodology is appropriate for the dual-segment structure; (iii) the historical pattern of revenue decline and elevate.io stall is well-documented across multiple filings — the bear case is evidentially well-supported.
Limits: (i) elevate.io's option value is genuinely uncertain — a single quarter of inflection could change the picture materially; (ii) the patent portfolio and OEM relationships could produce a discontinuous outcome (e.g. an acquisition by a larger creator-tools player) that no fundamental model captures.
Driver scoring rationale
- ai_beneficiary (35): elevate.io is positioned as a "platform that orchestrates AI-generated content" but is a workflow tool, not an AI infrastructure beneficiary. AI integrations (OpenAI speech, image gen, captions) are consumed by elevate.io, not built by them — value flows to OpenAI. Some indirect tailwind narrative ("more AI content = more editing needed") but no demonstrable AI-driven revenue line.
- operating_leverage (72): Capital-light SaaS with 88% gross margins and ~£3m fixed cost base. In theory, every incremental £ of subscription revenue drops largely to gross margin. Penalised because the base is sub-scale and going the wrong way.
- earnings_surprise_trend (20): Four consecutive years of declining revenue; elevate.io subscriber trajectory has stalled vs implied path.
- cyclicality (35): SaaS / tech — limited cyclical exposure, but creator economy and ad-funded broadcast demand have moderate cyclical sensitivity.
- moat (25): Real patented codec tech but micro player vs Adobe Premiere, DaVinci Resolve, Final Cut, CapCut. Switching costs minimal at the creator end; OEM/enterprise lock-in is partial.
- leverage (10): Net cash, no debt — fortress on the leverage axis. (Lower score = better on this scale.)
- earnings_quality (40): Heavy reliance on "Adjusted EBITDA pre LTIP and share option costs", aggressive capitalisation of dev costs (£1.55m in 2025, ~110% of revenue), persistent gap between reported EBITDA loss and headline metric.
- management_quality (40): Multiple strategic pivots, repeated dilutive raises at declining prices, but disclosure is detailed and management is invested. Cost control on the legacy division has been competent.
- growth_momentum (22): Revenue declining; the one growth datapoint (elevate.io paying users) has stalled.
Overall score: 215 / 1000
Poor fit for the strategy: indirect-at-best AI exposure, valuation requires the bull case to be correct, downside protection limited by ongoing cash burn and dilution risk. Operating-leverage profile is theoretically attractive but the revenue base is sub-scale and trending the wrong direction.